Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05018247 · ClinicalTrials.gov registry record · NA
Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05018247 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 14 participants.
The verdict
NCT05018247, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.
Interventions
- PROCEDURE Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2022-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05018247
The ClinicalTrials.gov registry entry for NCT05018247 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention is the first listed.
NCT05018247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05018247 about?
NCT05018247 is a clinical study titled "Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging". To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.
What is the current status of trial NCT05018247?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2021-05-04. Estimated completion is 2022-05-19.
What interventions are being tested in trial NCT05018247?
The interventions under investigation include: Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention (PROCEDURE).
Who is sponsoring clinical trial NCT05018247?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.